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ABSTRACT 
 
 Obesity is associated with insulin resistance, dyslipidemia, and cardiovascular 
disease. The current obesity epidemic is the result of surplus energy consumption. Excess 
energy is stored in expanding adipose tissue. Adipose tissue growth entails the 
enlargement of existing adipocytes, the formation of new fat cells from preexisting 
progenitors, and the coordinated development of supporting vasculature.  Identifying 
adipocyte progenitors and the mechanism of adipose tissue expansion is crucial for the 
development of new strategies to combat obesity and its complications.  
Though important progress has been made towards understanding the 
developmental origin of adipocytes, the identities of adipocyte progenitors are still not 
completely known. The main objective of this study is to determine whether endothelial 
cells of the adipose tissue can give rise to new adipocytes. Our results indicate that 
murine endothelial cells of adipose tissue are pluripotent and can potentially give rise to 
preadipocytes. Lineage tracing experiments using the VE-Cadherin-Cre transgenic mouse 
reveal localization of reporter genes in endothelial cells, preadipocytes and white and 
brown adipocytes. Moreover, capillary sprouts from human adipose tissue, which have 
predominantly endothelial cell characteristics, are found to express Zfp423, a 
preadipocyte determination factor. In response to PPARγ activation, endothelial 
characteristics of sprouting cells are progressively lost, and cells form structurally and 
biochemically defined adipocytes. Taken together, our data support an endothelial origin 
of a population of adipocytes. The ability of the vascular endothelium to give rise to 
 xii 
adipocytes may explain how angiogenesis and adipogenesis can be temporally and 
spatially coordinated. 
Analysis of BAT and WAT revealed that adipose depots have distinct 
compositions of adipocyte progenitors.  Of the CD45-CD29+Sca1+CD24+ progenitor 
population, only 17% and 52% express VE-Cadherin in WAT and BAT, respectively. 
Our data show that the number of these specific progenitors in BAT and WAT are highly 
variable and suggest that a considerable number of adipocytes progenitors may have a 
non-endothelial cell origin. Differences in composition and types of adipocyte 
progenitors may explain the differences in the adipocytes phenotypes that we observe in 
discrete depots.  
In brief, we find that the vascular endothelium gives rise to a population of brown 
and white fat cells, and that the number of endothelial-derived adipocyte progenitors 
residing in BAT and WAT is highly variable. These results expand our current 
understanding of adipose tissue growth, and, we hope, will accelerate the development of 
treatments for obesity-related complications. 
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CHAPTER I: Adipose Tissue in Human Health and Disease 
 
“Thou seest I have more flesh than another man, and therefore more frailty” 
William Shakespeare. Henry IV, Part I 
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Introduction 
Only recently in human history has the association between high body weight 
and poor health become readily apparent. For much of history, a combination of 
natural and artificial disasters caused mankind to be preoccupied with under-nutrition 
and disease-induced anorexia [1]. Drought, floods, blights, plagues, and human nature 
have made famine a frequent occurrence documented in ancient times through the 
writings of Plato, Thucydides, and Aristotle [2]. 
Famine has contributed to the downfall of many great civilizations [3]. The 
fall of the Roman Empire was partly attributed to famines brought on by severe 
transportation and communication challenges, which ultimately caused the deaths of 
thousands [4]. The infamous “Bread and Circuses” strategy of Roman emperors 
sprung from efforts to distribute free food in an attempt to avoid social unrest. 
Traditionally how well empires dealt with food shortage problems was directly 
correlated to their longevity [1].  
To the same extent, how well an organism deals with periods of starvation is 
tied to its survival over time. It is conceivable that an organ would evolve to meet the 
energy demands of an organism during periods of ecological instability. In humans 
and other vertebrate animals, this organ is the adipose tissue. The accumulation of 
fuel in discrete adipose depots allow for a better regulation of energy balance. First, 
adipose depots can be regulated by the central nervous system (CNS) specifically and 
efficiently via molecular signaling. Second, the adipose tissue itself can act as a 
metabolic sensor and effector by signaling to the brain [5]. Formation of a peripheral 
organ that can store fuel and interact with the CNS to meet energy needs allows an 
organism to adapt to the reality of an uncertain food supply. This work aims to 
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provide insight on the mechanism of adipose tissue growth. To give context and 
establish the importance of fat cell biology, we will briefly discuss the current obesity 
epidemic and prevailing theories regarding the role of adipose tissue in human health 
and disease. 
 
Obesity Epidemic 
Through 19th century, the significance of adipose tissue was most apparent in 
times of under-nutrition [1]. However, it is evident in the present obesity epidemic 
that adipose tissue function is also of particular importance in time of over-nutrition. 
In 2008, the World Health Organization (WHO) estimated that 1.5 billion adults 
worldwide were either obese or overweight. Obesity and overweight status are 
defined in terms of body mass index (BMI), the ratio between weight (kg) and the 
square of height (m2). Those with BMI ≥ 30 are obese and those with BMI ≥ 25 are 
overweight. According to Center for the Disease Control and Prevention (CDC), 
35.7% of adults in the US are obese (Figure 1.1). Approximately 12.5 million children 
are obese and it is forecasted that life expectancy will either decrease or no longer 
increase due to the significant disease burden associated with increase adiposity [6] 
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Figure 1.1. Rapid rise in the prevalence of obesity in the United States. Statistics 
reported by the CDC on the prevalence of obesity in adults in the US. Adapted from 
the CDC website (www.cdc.gov/obesity).  
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It is well established that obesity increases the risk of type II diabetes (T2D), 
hypertension, hyperlipidemia, ischemic heart disease and cancer [7-10]. The 
correlation between obesity and T2D is clearly mapped by epidemiological data 
(Figure 1.2).  An increase of 2 in BMI in overweight males can potentially reduce 
their lifespan by approximately one year [11-13]. Currently, our nation spend 147 
billion dollars to treat obesity-related illnesses with the poor being most affected [14]. 
Thus, the obesity epidemic, like famine is a significant social and biological crisis that 
must be addressed. 
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Obesity from an evolutionary perspective 
Thrifty genotype: There are several schools of thought regarding the cause of the 
growing obesity epidemic. In 1962, James Neel wrote a seminal paper suggesting that 
‘genetic thrift’ was the driving force behind our currently pandemic [15, 16]. He 
argued that perhaps people who were more efficient at storing energy were better 
suited for survival in times of ‘feast and famine’. According to Neel, natural selection 
would favor those with thrifty genotypes.  
The agricultural and technological revolutions drastically changed homo 
sapiens environment and lifestyle [17]. We are now able to consume more energy and 
exert less using technological advances. Furthermore, improvements in heating and 
clothing have drastically reduced our need to expend energy to keep ourselves warm 
via adaptive thermogenesis [18-21]. In the new environment, the thrifty genotype is 
maladaptive as it carries a higher risk of developing T2D. Neel pointed out that 
perhaps obesity was like sickle cell anemia, except multifaceted and is not traced to a 
single allele. Much like obesity, at some point it was evolutionarily advantageous to 
carry the sickle cell gene, however, this trait has become maladaptive in modern times 
and now leads to severe health complications [15]. 
The conceptual underpinnings of Neel’s hypothesis are true to some extent, 
because we do know that genes determine body weight and fat distribution as well as 
the development of T2D (Figure 1.3 and 1.4) [22]. Although a clear genetic link 
between obesity and T2D has been difficult to establish, certain genes have been 
implicated in both obesity and diabetes. For example, those who are homozygous for 
the affected allele of the fat-mass and obesity-related (FTO) gene are at higher risk for 
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diabetes and also at risk to be 2-3 kg heavier than those homozygous for the variant 
allele (Figure 1.5) [23-27]. 
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Figure 1.3.  Genomic Locations of Proven Signals of Nonautoimmune Forms of 
Diabetes. Signals are shown according to their location on each chromosome. Genes 
causing monogenic and selected syndromic forms of diabetes are shown to the left: 
genes implicated in maturity-onset diabetes of the young (red triangles) and those 
representing loci causal for other monogenic and syndromic forms of diabetes (green 
triangles). Common variants that have significant genomewide associations with 
multifactorial forms of diabetes are shown to the right (blue triangles); for these 
variants, the genes named within the triangles are indicative of signal position, but in 
most instances, formal proof that these are the specific genes responsible for the 
association is lacking. Adapted from McCarthy, M.I. (2010). Genomics, type 2 
diabetes, and obesity. N Engl J Med 363, 2339-2350. 
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Figure 1.4. Genomic Locations of Proven Signals of Body-Mass Index (BMI), 
Obesity, and Related Phenotypes. Signals are shown according to their location on 
each chromosome. Genes causing monogenic and selected syndromic forms of 
obesity (red triangles) are shown to the left. Common variants that have significant 
genomewide associations with BMI or multifactorial obesity are shown to the right: 
loci implicated in BMI or weight variation at the population level (solid blue 
triangles), additional loci identified in case–control analyses of extreme obesity (open 
blue triangles), and variants identified primarily because of their association with 
waist circumference or waist-to-hip ratio (solid green triangles). For the variants 
shown to the right, the genes named within the triangles are indicative of signal 
position, but in most instances, formal proof that these are the specific genes 
responsible for the association is lacking. Adapted from McCarthy, M.I. (2010). 
Genomics, type 2 diabetes, and obesity. N Engl J Med 363, 2339-2350. 
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Figure 1.5. Pathways to Type 2 Diabetes Implicated by Identified Common 
Variant Associations. Type 2 diabetes results when pancreatic beta cells are unable 
to secrete sufficient insulin to maintain normoglycemia, typically in the context of 
increasing peripheral insulin resistance. The beta cell abnormalities fundamental to 
type 2 diabetes are thought to include both reduced beta cell mass and disruptions of 
beta-cell function. Insulin resistance can be the consequence of obesity or of obesity-
independent abnormalities in the responses of muscle, fat, or liver to insulin. 
Examples of susceptibility variants that, given current evidence, are likely to 
influence predisposition to type 2 diabetes by means of each of these mechanisms are 
shown. Adapted from McCarthy, M.I. (2010). Genomics, type 2 diabetes, and obesity. 
N Engl J Med 363, 2339-2350. 
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Thrifty Phenotype: An alternative to Neel’s hypothesis is posed by David 
Barker, who argues that exposure to malnutrition in utero results in disturbances that 
lead to the impaired glucose tolerance and other metabolic syndromes [16, 28, 29].  
Epidemiological data support the Barker hypothesis. In 1944-1945, World War II 
devastated Western parts of Netherlands and famine ensued. During the Dutch famine, 
food was rationed and dairy intake dropped below 1000 calories [30]. It was found 
that fetal exposure to malnutrition during the first half of gestation resulted in 
significantly higher obesity rates in men and decreased glucose tolerance in adults [31, 
32]. Others have found that low birth-weights were associated with higher rates of 
diabetes [33-35]. Furthermore, studies in animal models involving nutrient restrictions 
and high-caloric feeding revealed that maternal and paternal health have profound and 
lasting effects on fetal endocrine function [36-38].  Several pieces of evidence suggest 
that fetal adaptation to uterine environment may negatively affect phenotype in adult 
life.   
Predator Release: Although Neel and Barker suggest different hypotheses for 
the alarming increase in obesity, they both cite adaptive mechanisms. A non-adaptive 
hypothesis has been suggested recently by John Speakman [39]. Speakman states that 
adaptive hypothesis might be flawed because a large population is still normal-weight. 
If indeed nature favored those especially efficient at storing fat, we would see high 
occurrences of obesity during historical periods of “feast.” His “predatory release” 
theory posits that the recent rise in obesity is instead due to genetic drift. In the 
‘hunter-and-gather’ days, predation selected against obese people. In the absence of 
predation, random mutations and genetic drifts could explain the rapid emergence of 
obesity [17].  
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Adipose Tissue 
The mechanism by which obesity has rapidly emerged is one of the most 
pressing public health issues of our era and is still hotly debated. However, the fact 
that it negatively impacts human health and happiness is undisputable. At the center 
of all discussions and of this body of work is the adipose tissue. There are two 
established types of adipose tissue: white adipose tissue (WAT) and brown adipose 
tissue (BAT). 
White Adipose Tissue: Excess caloric intake is stored in WAT, which is 
widely distributed in visceral and subcutaneous deposits [40]. Visceral fat depots are 
found in intra-abdominal, perigonadal and retroperitoneal regions. Subcutaneous fat 
depots are mostly found in the gluteal, inguinal and abdominal regions. Histologically, 
white adipocytes appear spherical with variable size, depending on the lipid droplet 
(unilocular) within them. Mitochondria present in white adipocytes are thin and 
elongated (Figure 1.6) [41].  
WAT has two primary functions. First, it stores energy in the form of 
triglycerides in times of surplus and releases energy in the form of fatty acids in times 
of fasting. Second, it serves as the largest endocrine organ in the body, secreting 
adipokines such as leptin and adiponectin that are vital in regulating energy balance.  
Brown Adipose Tissue: Adipose tissue is composed of not only white 
adipocytes, but also brown adipocytes, which are involved in energy expenditure 
rather than energy storage. BAT is present in the axillary, cervical, perirenal and 
periadrenal regions of newborns [42]. Although it was once thought that BAT 
becomes relatively insignificant in older people, Cypress et al. recently demonstrated 
through [18F]-2-fluoro-D-2-deoxy-D-glucose (FDG) positron emission tomography 
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(PET) that metabolically active BAT is present in the cervical, supraclavicular, 
axillary and paravertebral regions of normal adults [43]. Others have since confirmed 
that BAT exists in human adults [19, 20, 42, 44, 45]. Histologically, brown adipocytes 
are polygonal and have many small lipid droplets (multilocular) within them. Their 
mitochondria are abundant and appear large, spherical and filled with laminar cristae 
(Figure 1.6) [41]. 
Brown adipocytes express uncoupling protein-1 (UCP-1), a 32 kDa protein 
that permits protons to leak through the inner mitochondrion membrane [46]. It 
uncouples ATP synthesis from the electron transport chain, allowing production of 
heat rather than ATP from the electrochemical gradient [47]. UCP-1 is specific to 
BAT and is entirely responsible for non-shivering thermogenesis [48]. In humans, 
BAT function is inversely correlated with obesity [21, 49], while mice genetically 
engineered to have reduced brown fat develop T2D and obesity [50, 51]. Because of 
its anti-obesity effect, induction of BAT in humans represents a potential tool in the 
prevention of obesity and its metabolic consequences  
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Figure 1.6. Histology of BAT and WAT.  Brown adipocytes are multilocular with 
abundant spherical mitochondria (A and C) and white adipocytes have unilocular 
lipid droplets and flattened mitochondria (B and D). In some WAT, there is presence 
of brown adipocytes, indicated by expression of UCP-1, distinct multilocular 
appearance and spherical mitochondria (E and F). m: mitochondria, l: lipid droplet, 
m: mitochondria, n: nucleus, cap: capillary. Modified from Frontini, A. and S. Cinti, 
Distribution and development of brown adipocytes in the murine and human adipose 
organ. Cell Metab, 2010. 11(4): p. 253-6 and Cinti, S., Transdifferentiation
properties of adipocytes in the adipose organ. Am J Physiol Endocrinol Metab,2009. 297(5): p. E977-­‐86.
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Stromal Vascular Fraction of Adipose tissue: White adipocytes and brown 
adipocytes are supported by cells in the stromal vascular fraction (SVF) of the adipose 
tissue. The SVF loosely defines a population of cells isolated from adipose tissue via 
collagenase digestion. It is comprised of all non-adipocyte cells, including 
preadipocytes, autonomic nerves, vasculature, leukocytes and connective tissue. The 
SVF plays a crucial role in supporting the maintenance and expansion of the adipose 
tissue. 
Obesity and diabetes at the molecular perspective: 
At the molecular level, it is thought that adipose tissue dysfunction in obesity 
leads to insulin resistance. Although this hypothesis is still evolving, it is widely 
accepted that obesity-related insulin resistance is in part due to (1) a sequestration 
defect that leads to free fatty acid (FFA) circulation, deposition and subsequent 
disruption of insulin signaling and (2) changes in adipokine secretion that impair 
adipogenesis and decrease peripheral insulin sensitivity [52].  
Lipotoxicity: The hypothesis that FFA circulation and deposition in peripheral 
organs cause insulin resistance is supported by studies demonstrating that short-term 
FFA infusion acutely induces insulin resistance. This is further corroborated by 
findings that intra-myocyte lipid content correlate positively with insulin resistance 
better than BMI measurements [53-55]. Consistent with this conclusion is the 
observation that patients who have congenital lipodystrophies have high levels of 
circulating triglycerides and are also insulin resistant [56]. Mouse lipodystrophic 
models also show glucose impairment in the absence of fat [57, 58]. Although it is 
widely accepted, Karpe and colleagues recently challenged the hypothesis that there is 
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higher plasma concentration of FFA in cases of obesity and diabetes. They found that 
when normalized for mass, adipose tissue FFA release is decreased [59]. It was also 
noted that women tend to have higher FFA than men, however they are more insulin 
sensitive.  
Inflammation: Besides the “lipotoxic” effect, adipose tissue dysfunction can 
also lead to perturbation in adipokine secretion to cause insulin resistance. Patients 
who are obese have lower levels of plasma adiponectin, an insulin sensitizer [60, 61]. 
In the initial stages of obesity, adipocytes grow in size to accommodate excess 
nutrition. It has been found that hypertrophied adipocytes secrete higher level of 
chemo-attractants to recruit immune cells [52, 62]. Inflammation of the visceral 
adipose tissue has been correlated with insulin resistance [63]. In obese patients, 
macrophages can represent as much as 40% of cells [64]. Macrophages and 
adipocytes themselves in turn secrete inflammatory signals, such as tumor necrosis 
factor α (TNF-α) and interleukin-1β  (IL-1β). TNF-α has been show to negatively 
affect insulin substrate receptor (IRS) Ser/Thr phosphorylation, a key mediator of 
insulin signaling [52, 65].  
Beyond impairing insulin signaling, TNF-α also down-regulates peroxisome 
proliferator-activated receptor γ (PPARγ) at the transcriptional and post-translational 
levels. PPARγ is a transcription factor that is necessary and sufficient for 
adipogenesis [66]. It is required for the development and maintenance of adipose 
tissue and is important in many tissues as demonstrated by numerous knock-out 
studies (Table 1). Thus, not only does TNF-α disrupt insulin signaling, it impairs the 
formation of new healthy adipocytes to help regulate metabolism. 
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Endothelial 
cells 
Nicol et al. 2005 
[71] 
 
 
 
Kleinhenz et al, 
2009 [72] 
 
 
 
 
 
Kanda et al., 
2009 [73] 
 
 
 
Tie2Cre/ PPARγfl/fl 
 
 
 
 
Tie2Cre/ PPARγfl/fl 
 
 
 
 
 
 
Tie2Cre/ PPARγfl/fl 
 
 
 
 
HFD-induced 
hypertension 
 
 
 
Hypertensive. 
Impaired Ach-
induced NO 
production and 
vasorelaxation  
 
 
Increased insulin 
sensitivity, fasting 
plasma FFA and TG 
levels, decreased TG 
accumulation in 
skeletal muscle as 
compared to WT 
mice. Fat mass 
reduced compared to 
WT on HF diet. 
TZD did not 
improve HFD-
induced 
hypertension 
 
 
 
 
 
 
 
 
TZD failed to 
increase 
epididymal fat 
mass in knockouts 
as seen in controls. 
Also, did not lower 
plasma FFA and 
triglyceride levels, 
suggesting direct 
action on 
endothelial cells. 
 
*Table displays a limited list of models that are most relevant to this study 
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Although the mechanisms by which obesity leads to diabetes are still debated 
on the genetic and molecular levels, it is clear that the healthy adipocytes are integral 
to metabolism. It would follow that generating healthy adipocytes would be beneficial 
in at least two ways, first by sequestering free fatty acid and decreasing lipotoxicity 
and second by normalizing adipokines secretion to maintain insulin sensitivity. This 
study aims to establish the origin of new adipocytes. 
 
Adipocyte expansion:  
 Adipocytes expand either by multiplying in numbers (hyperplasia) or by 
increasing in size (hypertrophy) [74-76]. Analysis of subcutaneous fat and visceral fat 
has led many researchers to conclude that hyperplastic growth may have a protective 
effect on metabolic dysfunction [77, 78]. While increase in visceral fat seen in 
abdominal obesity is associated with metabolic disease, increase in subcutaneous fat 
seen in peripheral obesity is associated with metabolic health [79-83]. Rate of 
proliferation of precursors isolated from subcutaneous adipose tissue is higher than 
that of visceral adipose tissue, and thus it is indirectly concluded that hyperplastic 
growth is metabolically beneficial [77, 78, 84]. 
New adipocyte formation is part of physiological growth. Experiments using 
radioactive tracers revealed that new adipocytes form and die throughout life [85-87]. 
Through analyzing adipose tissue of people who were exposed to radiation during 
atomic testing, Spalding et al. estimated that the rate of adipocyte turnover is 
approximately 10% per year [88]. Mature adipocytes do not divide, thus precursors 
exist and are constantly making adipocytes and renewing themselves in the adipose 
tissue. 
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Adipocyte precursors reside in the adipose tissue vasculature [89-91]. 
Adipogenesis and angiogenesis are temporally and spatially coupled in development 
[92-95]. Studying postnatal epididymal adipose tissue, Han et al. found that 
angiogenesis precedes adipogenesis and that impairment of the VEGF/VERGFR2 
signaling pathway disrupts adipogenesis [93]. This result is further corroborated by 
findings from Kolonin and colleagues demonstrating that targeting adipose tissue 
endothelial cells with apoptotic peptide inhibited weigh gain in mice and primates fed 
high fat diet [96, 97]. It is important to note that some of the anti-obesity effect 
associated with anti-angiogenesis agents may be due to a confounding anorexic affect, 
and not to a direct effect on adipocyte growth and development. 
Although the mechanisms by which anti-angiogenic drugs decrease weight 
gain are still debated, it is clear that a close relationship exists between cells in the 
vasculature and adipocytes. There are several microscopy studies that illustrated the 
unique relationship between pericytes and adipocytes. Micrographs depict the 
juxtaposition between preadipocytes and vasculature, some suggesting that 
preadipocytes might be emerging from the vasculature [98-101].  In 1983, Hausman 
et al. showed that endothelial cells of adipose tissue in rats have many processions 
into the lumen and perivascular space. Some of these endothelial processes are 
contiguous with adipocytes [102]. These morphological evidences are suggestive of a 
pericyte-endothelial nature of preadipocytes and adipocytes [95].  
Morphological studies set the stage for the recent genetic experiments that 
have shed light on the identity of the adipocyte precursors. Development of novel 
genetic tools has allowed for the tracing of cell lineages throughout a life of the 
mouse [103, 104]. Tang et al. generated a knock-in mouse that has the tetracycline 
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transactivator (tTA) under the control of PPARγ [91]. Then they crossed the tTA-
PPARγ mouse to one that has Cre-recombinase under the control of the tetracycline 
response element (TRE). The resulting transgenic animal was then mated with two 
reporter strains, one which as an indelible LacZ signal and the other with mitotic-
sensitive GFP signal. The reporter would be active in the absence of doxycline (Dox; 
Tet-off) but would be inactive in its presence. Using these two models, the authors 
discovered that preadipocyte are present before birth, and most WAT expansion 
occurs postnatal. 
Cells FACS sorted from PPARγ-GFP mouse for the reporter signal also 
expressed Sca-1 and CD34. Using stromal vascular particulate (SVP) isolation 
techniques, the Graff laboratory found that the GFP+ cells are located near vessels 
and co-localize with cells expressing pericytes markers, NG2, SMA, and PDFGRβ 
[91]. Based on these findings, Tang et al. concluded that mural cells of the adipose 
tissue give rise to adipocytes. To test this hypothesis they made a PDFGRβ-Cre/R26R 
reporter mouse. It was found that adipocytes indeed expressed LacZ in these 
transgenic animals, further supporting a pericytic origin of new adipocytes. Tang et al. 
reported that cells expressing PDGFRβ in the vasculature of the adipose tissue have 
the capacity to undergo adipogenesis when transplanted into nude mice [91]. In 
culture, isolated PDGFRβ+ cells from WAT, but not from other tissues e.g. kidney, 
were able to undergo adipogenesis in the presence of a thiazolidinedione (TZD), a 
PPARγ agonist. Thus, the vasculature of the adipose organ not only supports the 
maintenance and expansion of adipose tissue, but also harbors cells that can 
differentiate into adipocytes.  
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An important aspect to realize is that these results do not exclude the 
possibility that endothelial cells may give rise to new adipocytes. It is reported that 
endothelial cells also express PPARγ [71-73]. PDGFRβ is also expressed in 
endothelial cells of microvasculature and is not restricted to pericytes [105-107]. Thus, 
although the Graff laboratory demonstrated that pericytes can give rise to adipocytes, 
questions remain whether cells of an endothelial lineage have the same capacity. The 
first goal of this study is to address this question using morphological and genetic 
approaches. 
Around the same time, a seminal study by Rodeheffer et al. revealed the 
identity of the early adipocyte progenitors [108]. The Friedman group used 
fluorescence-activated cell sorting (FACS) to isolate cells expressing stem cell 
markers CD29, CD34, Sca-1 and CD24 (CD24+) from the SVF. Within this 
population, they also depleted cells expressing known lineage markers: CD31, CD45 
and Ter119 (Lin-:CD24+). Approximately 50,000 of Lin-:CD24+ cells from 
ubiquitin-GFP mice were transplanted into wild-type and A-Zip lipodystrophic mice 
[58]. Although no GFP+ adipocytes were found in wild-type mice, GFP+ adipocytes 
were present in newly-formed fat pads of the A-Zip mice 12 weeks after injection of 
the CD24+ progenitors. Furthermore, these newly-formed adipocytes were able to 
improve the insulin resistance associated with the A-Zip lipodystrophic model. These 
experiments not only revealed the identity of an early progenitor population, but they 
also demonstrated the importance of the microenvironment in adipogenesis. 
With respect to diet-induced obesity, changes in the microenvironment appear 
to play an important role in regulation of adipogenesis. Rodeheffer et al. illustrated 
this with transplantation experiments involving CD24+ cells from leptin-luciferase 
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transgenic animals [108]. In this model, luciferase expression is restricted to the 
adipose tissue [109]. Two weeks after injection, wild-type mice were fed high fat diet 
for six weeks. Luciferase signal was detected in three of the eight animals injected 
with CD24+ cells and subsequently fed HFD. The development of new adipocytes 
from CD24+ precursors in A-Zip and HFD-fed animals indicates that adipose 
expansion from transplanted cells may only occur in a permissive environment. 
Rodeheffer et al. demonstrated the importance of the microenvironment and 
its role in determining cell fate. Cells in the SVF are capable of differentiating into a 
number of cell types such as osteocytes, chondrocytes, adipocytes, myocytes, and 
endothelial cells in vitro [90, 91, 108, 110-116]. Furthermore, Planat-Benard and 
colleagues demonstrated that adipocytes can be stimulated to become endothelial cells 
in culture [115]. Cellular plasticity exists and cell fate is less rigid than thought.  In 
this study, we examine whether endothelial cells arising from the aorta of mice have 
the capacity to become adipocyte, similar to cells in the adipose tissue.   
Up to date,  the seminal works on adipocyte progenitor cells have been 
focused on white adipocyte. This may be because only recently has BAT been 
discovered to be relevant to human adult health. BAT and WAT are both mesodermal 
and it was assumed that they share the same origin. However, two recent studies have 
shown that this may not be the case. The Conlon and the Spiegelman laboratories 
have found that a population of brown adipocytes is derived from a muscle-related 
En1 and Myf5 lineages [117, 118]. 
Study by Seale et al. also suggests that there are several origins of brown 
adipocytes. They noted that brown adipocytes stimulated by β-adrenergic agonists are 
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not derived from a Myf5+ lineage. The concept that multiple cell types can give rise 
to brown adipocytes is supported by experiments that show transdifferentiation of 
white and brown adipocytes under certain physiological conditions. For example, in 
the presence of cold or after treatment with β3-adrenoceptor agonist, it has been found 
that white adipocytes can transdifferentiate into brown adipocyte [119-122]. Under 
obesogenic conditions, brown adipocyte accumulate lipid and take on storage function 
like white adipocytes [123]. From an evolutionary perspective, multiple origins of 
brown adipocyte might be beneficial, as in the right physiological and 
pathophysiological conditions, pluripotent cells residing in specific organs can be 
programmed to take on function that would ensure optimal performance. 
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Recent Development: Since the work described herein began, there have been 
several important papers published by the Spiegelman’s laboratory on this subject. 
Although these studies were completed too late to directly influence the design of this 
work, their findings support our hypothesis and will be discussed. In 2010, Gupta et 
al. reported that finger protein 423 (ZFP423) is enriched in fibroblast cell lines that 
have the capacity to undergo adipogenesis (Figure 1.7) [124]. Overexpression of 
ZFP423 in NIH3T3 cells, which do not undergo adipogenesis, causes them to 
differentiate into adipocytes under permissive conditions. The ZFP423 knock-out 
mouse has diminished and irregular brown and white adipocytes. It was concluded 
that ZFP423 was an adipocyte predetermination factor.   
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Figure 1.7. The C2H2 zinc finger protein Zfp423 is enriched in preadipocytes. Oil-red-O 
(ORO) staining of preadipocyte cell lines (a) and non-adipogenic cells lines (b) at six days 
following the induction of adipogenesis with DMI. (c) Zfp423 expression in sub-confluent 
Swiss 3T3 subclones and existing preadipocyte and fibroblast cell lines. (n=3 replicates per 
cell line). In this, and other figures, bars represent mean ± standard deviation from the mean. 
(d) Western Blot of endogenous Zfp423 protein levels in fibroblast cell lines grown under 
non-differentiating conditions. Adapted from: Gupta, R.K., et al., Transcriptional control of 
preadipocyte determination by Zfp423. Nature, 2010. 464(7288): p. 619-23. 
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The Spiegelman laboratory then went on to make ZFP423GFP reporter animal 
[89]. This animal expresses GFP under a non-functional ZFP423 transgene, allowing 
for the identification of precursor cells. In their study, Gupta et al. found localization 
of ZFP423 to pericytes and endothelial cells of the adipose tissue (Figure 1.8). This 
supports the results of our experiments. Interestingly, ZFP423 is only expressed in 
endothelial cells of the adipose tissue and not in other tissues, e.g. muscle. This may 
reinforce the concept that environment controls gene expression on the molecular and 
global levels. 
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Figure 1.8. GFP+ Preadipocytes Reside in the Adipose Vasculature as a Subset of Both 
Pericytes and Capillary Endothelial Cells (A and B) Confocal images of adult inguinal 
WAT stained with antibodies recognizing GFP (red) and the endothelial cell protein CD31 
(green), with nuclei counterstained with DAPI. In (A), note the expression of GFP in mature 
adipocytes and in some blood vessels (∗). In (B), note the expression of GFP in a subset of 
perivascular cells (arrow) and in a subset of endothelial cells (arrowhead) of the blood vessel 
highlighted in (A).(C) Confocal image of developing inguinal WAT from postnatal day 4 
mice stained with antibodies recognizing GFP (red) and the endothelial cell protein CD31 
(green). Note the expression of GFP in a subset of perivascular cells (arrow) and in a strong 
subset of endothelial cells (arrowhead) even before the full development of mature adipocytes 
at this stage.(D and E) Confocal images of embryonic day 18.5 interscapular BAT stained 
with the same antibodies shown in (A)–(C). In (D), note the expression of GFP in mature 
adipocytes and in numerous perivascular cells (arrows). In (E), note the expression of GFP in 
a subset of endothelial cells (arrowhead).(F) Confocal image of skeletal muscle directly 
adjacent to the interscapular BAT shown in (D) and (E). Note the absence of GFP+ cells in 
the vasculature of this tissue. Adapted from Gupta, R.K., et al., Zfp423 expression identifies 
committed preadipocytes and localizes to adipose endothelial and perivascular cells. Cell 
Metab, 2012. 15(2): p. 230-9 
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SPECIFIC AIM 
The goal of this body of work is to further characterize the identity or 
identities of the adipocyte progenitors.  Adipose tissue expansion requires the 
enlargement of existing adipocytes, differentiation of adipocyte progenitors, and the 
development of a supporting vascular network. Evidence suggests that adipocyte 
precursors reside in the vasculature of the adipose tissue. Recently, Tang et al. have 
shown that pericytes of adipose tissue vessels give rise to adipocytes. Pericytic origin 
of adipocytes has been corroborated by other studies. However, it is not completely 
clear if endothelial and adipocytes may also share the same origin.  
It has also been established that microenvironment is crucial in adipogenesis. 
Pericytes from the kidneys are not able to undergo adipogenesis. Furthermore, 
adipocytes progenitors from the adipose tissue will not undergo adipogenesis when 
transplanted into host animals unless the environment of the recipient adipose tissue is 
conducive to the formation of new adipocytes. This brings into question whether 
progenitor cells of other organ systems can be stimulated to make new adipocytes if 
permissive conditions in vitro are established.  
We hope to contribute to the current knowledge of adipocyte progenitors. The 
specific aims of this study are: 
1. To determine whether cells of the endothelial lineage may give rise to 
new adipocytes during physiological growth.  
2. To determine whether endothelial cells arising from the aorta have the 
capacity to undergo adipogenesis. 
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CHAPTER II: Origin of white and brown adipocyte form vascular endothelium 
 
 
This chapter represents the manuscript: 
Tran, K.-V.*, Gealekman, O.*, Frontini, A.*,  Zingaretti, M. C., Morroni, M., 
Giordanom, A., Smorlesi, A., Perugini, J., De Matteis, R., Sbarbati, A., Corvera, S., 
Cinti, S. (2012) The vascular endothelium of the adipose tissue gives rise to both 
white and brown fat cells. Cell Metab. 15, 222-229.  
*These authors contributed equally 
 
This work is a collaborative effort between the Corvera and Cinti laboratories. Animal 
experiments were performed by Khanh-Van Tran and Andrea Frontini. Real-time 
PCR and FACS analysis were performed by Khanh-Van Tran. Immunohistochemistry 
was performed by Olga Gealekman. All electron microscopy were performed by the 
Cinti laboratory. 
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SUMMARY 
 Adipose tissue expansion involves the enlargement of existing adipocytes, the 
formation of new cells from committed preadipocytes, and the coordinated 
development of the tissue vascular network. Here we find that murine endothelial 
cells (EC) of classic white and brown fat depots share ultrastructural characteristics 
with pericytes, which are pluripotent and can potentially give rise to preadipocytes. 
Lineage tracing experiments using the VE-cadherin promoter reveal localization of 
reporter genes in EC, and also in preadipocytes and adipocytes of white and brown fat 
depots. Furthermore, capillary sprouts from human adipose tissue, which have 
predominantly EC characteristics, are found to express Zfp423, a recently identified 
marker of preadipocyte determination. In response to PPARγ activation, endothelial 
characteristics of sprouting cells are progressively lost, and cells form structurally and 
biochemically defined adipocytes. Together these data support an endothelial origin 
of murine and human adipocytes, suggesting a model for how adipogenesis and 
angiogenesis are coordinated during adipose tissue expansion. 
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INTRODUCTION 
 The obesity epidemic associated with increased risk of type 2 diabetes have 
underscored the need to understand the relationship between excess caloric intake, 
white adipose tissue (WAT) development, and metabolic disease. Mammals, 
including humans, also have metabolically active brown adipose tissue (BAT) [20, 21, 
43], and BAT precursors can be found in adipose organ of adult humans [125]. BAT 
has anti-obesity properties, therefore the mechanisms by which brown adipocytes 
emerge under different physiological and pharmacological conditions is under 
intensive investigation. 
 
 Adipose tissue growth is mediated by adipocyte hypertrophy, but in obesity 
adipose tissue may reach 60-70% of body weight, requiring hyperplasic growth [76, 
126]. Therefore, defining the identity of adipocyte precursors is an area of intense 
interest. Markers of precursor cells giving rise to committed preadipocytes are being 
identified [124], and a population of early adipocyte progenitor cells expressing stem 
cell markers has been characterized in mouse WAT [108]. Furthermore, PPARγ 
lineage tracing studies indicate that the vascular wall of adipose tissue capillaries 
represents the niche of adipocyte precursors[91]. 
 
 Adipose tissue growth requires concomitant expansion of its capillary network 
[127, 128], but how adipocyte formation and capillary expansion are coordinated is 
unclear. The stromal-vascular fraction (SVF) cells of adipose tissue differentiate in-
vitro into either an adipogenic or a perivascular phenotype [114, 129-132], but the 
identity of these progenitor cells in-vivo is unknown. Since cells morphological 
 34 
 
34 
features are closely related to their function, a careful ultrastractural analysis during 
development could provide information on the origin and anatomical localization of 
adipose tissue precursors.  
 
VE-cadherin is required for the formation of vasculature, and is expressed 
specifically in endothelial cells (EC) of fetal and adult mice.  VE-cadherin-Cre-
dependent LacZ and eGFP reporter strains show localization of the reporters in EC of 
many tissues [133-138]. However, VE-cadherin is also expressed in sub-populations 
of hematopoietic cells before E11.5, and thus their descendants are potentially 
labelled into adulthood [136]. To circumvent this problem, mice in which VE-
cadherin-driven Cre is induced during adulthood have also been created, resulting in 
negligible excision (lower than 0.4%) in the hematopoietic lineage [134]. Lineage 
tracing with constitutive and inducible VE-cadherin driven Cre can provide 
information on the relationship between vascular and adipose cell development by 
allowing the identification of cells that express this EC gene at any point during 
embryonic and postnatal periods. 
 
An additional tool to define the relationships between newly formed 
vasculature and the genesis of new adipocytes is the use of mouse and human adipose 
tissue explants cultured ex-vivo [139, 140]. In this manuscript, we have used these 
morphological, genetic and functional approaches, and obtained evidence that EC of 
capillaries in developing WAT and BAT depots can give rise to mature adipocytes. 
Our findings will enable further studies of the biochemical and physiological cues 
controlling adipose tissue growth. 
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RESULTS AND DISCUSSION 
Ultrastructural identification of endothelial-pericytic cells as possible intermediate 
between EC and preadipocytes 
 Before birth rat (Figure 2.1A) and mouse (not illustrated) epididymal fat 
(eWAT) shows the typical features of a poorly differentiated mesenchymal tissue, 
consisting of a homogeneous population of fibroblast-like cells, often in mitosis 
(Figure 2.1A, m), in a loose connective matrix with small and sparse capillaries 
(Figure 2.1A, asterisks). In contrast, at postnatal day 6-8 (P6-8) (Figure 2.1B), well-
circumscribed areas with majority of cells identifiable as adipocytes due to the 
predominantly unilocular cytoplasmic lipid droplets (Figure 1B, yellowish colour in 
semi-thin section), are observed. These areas are delimited by fibroblast-like cells, 
and contain numerous large capillaries (Figure 2.1B, asterisks). These are about 3-fold 
larger than capillaries found in eWAT of adult animals, suggesting they have 
functions additional to oxygen and nutrient exchange. Adipogenesis appears to be 
restricted into these vasculo-adipocytic islets. Electron microscopy of these islets 
reveals dense collagen fibrils in the interstitial matrix, and thick capillary walls due to 
the presence of abundant pericytes (Figure 2.1C and D). Most of the cells located in 
the peri-capillary position of the vasculo-adipocytic islets, correspond to the cells 
described above by EM, and show nuclear staining for transcription factors widely 
considered as markers of adipogenic conversion, such as PPARγ, C/EBPα and 
C/EBPβ (Figure 2.S1A-C). These results are consistent with studies suggesting that 
pericytes are precursors of preadipocytes [91, 101]. Some EC are also positive for 
C/EBPβ (Figure 2.S1D, arrowhead), which is located upstream of PPARγ and 
C/EBPα in transcriptional control of adipogenesis [141].  
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Figure 2.1: Murine embryonic and postnatal eWAT morphology. A. eWAT depot 
at E18 composed of poorly differentiated mesenchymal cells(m = mitosis; some 
capillaries indicated with asterisk). B. eWAT at P7, where adipocytes appear 
yellowish in areas with abundant large capillaries (asterisks). C,D. Electron 
Microscope micrograph of a vasculo-adipocytic islet showing EC (e; elongated cells), 
tight junctions (tj), pericytes (p; poorly differentiated cells with glycogengranules and 
surrounded by a distinct basal membrane),preadipocytes (pa; cells with small lipid 
droplets, (L)), andglycogen granules in pericyte (arrow).  
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 In about 1-3% of vasculo-adipocytic islet capillaries, some EC exhibited novel, 
unusual features by being exposed to the capillary lumen, but also extended over a 
vicinal EC to adopt a pericytic position (Figure 2.2 A-C, endothelial-pericytic cells). 
Importantly, the junction of these cells with adjacent EC was composed of typical 
oblique tight junctions (Figure 2.2C, arrow), confirming the endothelial nature of 
these cells. EC and pericytes were sometimes joined by tight junctions between a 
protrusion of the EC crossing the basal membrane, and the complementary 
indentation in the pericyte (Figure 2.S1E). Some of the EC and endothelial-pericytic 
cells contain glycogen granules (Figure 2.2D-F, arrows), a characteristic feature of 
adipocyte progenitors [142]. Almost all pericytes (Figure 2.2D), some EC (Figure 
2.2E, arrow), and cells that are partially associated with the capillary wall and also 
abut into the interstitial space (Figure 2.2F) also contain glycogen particles. These 
data reveal a complex relationship between cells in the vasculo-adipocytic islets 
where extensive adipogenesis is ongoing, and suggest that endothelial-pericytic cells 
represent an intermediate between endothelial and preadipocyte stages (drawing in 
Figure 2.S1F). 
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Figure 2.2 Endothelial cells in pericytic position A. EC and 
pericytes of a capillary wall (asterisk indicates the capillary 
lumen). B. Enlargement of the black squared area in E 
revealing EC in endothelial-pericytic position. C. Enlargement 
of the red squared area in E highlighting typical oblique tight 
junction (arrow) joining cell in endothelial-pericytic position to 
adjacent EC. D. Example of cell in endothelial-pericytic 
position containing abundant glycogen (arrows). E. Example of 
a "pure" EC containing abundant glycogen (arrow). F. 
Example of a cell partially associated with the capillary wall 
(arrowheads) and partially abutting into the interstitial space.  
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Lineage tracing studies show an endothelial origin of adipocytes 
 Data shown above suggest that EC may be amongst the cells that give rise to 
new adipocytes. To address this hypothesis directly we used VE-cadherin promoter-
driven lineage tracing. VE-cadherin was expressed only in EC, and not in pericytes 
(red arrowhead) or adipocytes, of subcutaneous (scWAT) (Figure 2.3A) and eWAT 
(data not shown) of adult animals. Similarly, prior to adipocyte development in fetal 
and early postnatal eWAT (Figure 2.3B, C) and scWAT (not shown) of VE-cadherin-
Cre/R26R-LacZ mice, only EC were X-gal positive. In contrast, from P6-8 (Figure 
2.3D, E) to adult (Figure 2.S2A), adipocytes at different stages of lipid accumulation 
in eWAT and scWAT were also X-gal positive, indicating that VE-cadherin promoter 
was expressed at some point during adipocyte development. Control animals were 
always X-gal negative (Figure 2.S2B). To verify that the reporter was localized to the 
adipocyte cytoplasm, we used EM and observed a precise localisation of X-gal 
crystals in EC, pericytes, adipocytes (Figure 2.S2C), and preadipocytes (Figure 
2.S2D). Similar results were found using eGFP as a reporter; in developing eWAT 
adipocytes of VE-cadherin-Cre/R26R-eGFP mice, perilipin and eGFP colocalized in 
adipocytes (Figure 2.3F). Internal positive control (vessels), and other eGFP positive 
adipocytes are shown in Figure 2.S2E. These results further support the hypothesis 
that adipocytes can develop in vivo from cells of endothelial origin. 
 
 These data prompted us to investigate whether brown adipocytes might also 
have an endothelial origin. Immunohistochemistry for VE-cadherin confirmed its 
presence in EC and its absence in BAT pericytes and adipocytes (not illustrated). 
However, the interscapular region of E17-19 VE-cadherin-Cre/R26R-LacZ mice 
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showed strong X-gal staining in both EC and adipocytes (Figure 2.3G, H), while in 
the surrounding muscles only EC were stained (Figure 2.3G). The X-gal staining 
colocalized with the classical brown adipocyte marker UCP-1 (Compare Figure 2.3I 
and 2.3L). Moreover, in the developing interscapular brown fat depot (Figure 2.S3A-
B), some ECs display characteristic markers (Figure 2.S3C-E) and structural features 
(glycogen and mitochondria) of UCP-1- positive brown adipocyte precursors (Figure 
2.S3F-I). Taken together, these data strongly suggest that EC of developing WAT and 
BAT capillaries are a source of adipocyte precursors. Further evidence supporting the 
possibility that certain EC populations can give rise to adipocytes is the finding by 
Gupta et al (B. Spiegelman and R. Gupta personal communication) that pericytes and 
some EC of mouse adipose tissue express GFP driven by the promoter for Zfp423, 
which marks cells determined to form preadipocytes [124]. Moreover, PPARγ 
excision with the use of the Tie-2 promoter driven Cre-recombinase, which is 
expressed in a mosaic pattern in capillary endothelium [143], results in a decrease in 
adiposity and adipocyte size in response to rosiglitazone treatment in a manner 
dependent on endothelial, but not bone-marrow, PPARγ expression [144]. These 
findings constitute further evidence supporting the possibility that certain EC 
populations can give rise to adipocytes  
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Figure 2.3: VE-Cadherin lineage tracing in WAT and BAT. A. 
Immunohistochemical analysis on scWAT from VE-cadherin-Cre/R26Rmice 
showing the specific expression of VE-cadherin only in EC (brown), note the 
negative pericytes indicated by red arrowhead. B, C. In early neonatal eWAT only 
vasculature is X-gal positive. D, E. scWAT (D) and eWAT (E) from P7 mice 
revealing X-gal staining (arrows) in developing and mature adipocytes. F. Confocal 
microscopy of eWAT from VE-cadherin-Cre/eGFPRmice showing a single optical 
plane of adipocytes (arrows), containing eGFP (green) and perilipin (red). Some 
eGFP-negative/perilipin-positive adipocytes are also visible (L). G. X-gal positive 
staining in developing BAT, and in muscle capillaries. H. Enlargement of the squared 
area in G. I, L. X-gal (I) and UCP-1 (L) co-localization to brown adipocytes (arrows). 
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Figure 2.3  
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 A hematopoietic origin of adipocytes has been suggested [145-147]. To exclude 
the possibility that X-gal positive adipocytes originate from hematopoietic lineage, we 
complemented our studies with a tamoxifen-inducible transgenic VE-cadherin-
CreERT2 model in which cells derived from hematopoietic precursors are not labeled 
[134]. VE-cadherin-CreERT2/R26R-LacZ mice at eight weeks of age were induced by 
tamoxifen injection for five consecutive days. Three weeks later X-gal staining was 
observed in capillaries of adipose tissue, but also in numerous adipocytes distributed 
among the eWAT (Figure 2.4B, C) inguinal (E, F) and brown (H, I) depots. Number 
of X-gal positive adipocytes was lower, as compared to the results described above, 
possibly due to a lower number of adipocytes being formed during this postnatal 
expansion period, but still clearly significantly above the background observed in 
negative controls (Figure 2.4A, D, G). PPARγ agonists affect murine adipose tissue 
by increasing multilocularization of existing adipocytes and by stimulating pre-
adipocyte differentiation into mature adipocytes [122, 148]. Mice treated with 
rosiglitazone for three weeks following induction displayed numerous multilocular 
adipocytes, many of which were X-gal positive (Figure S2.3J-L). Thus, under both 
normal and stimulated adipogenesis, adipocytes arise from VE-cadherin expressing 
progenitors non-hematopoietic origin.  
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Figure 2.4. VE-Cadherin fate tracing in WAT and BAT. eWAT (B, C), scWAT (E, 
F), and BAT (H, I) adipose tissue from VE-cadherin-CreERT2-/+/R26R-/+ mice 
showing X-gal positive staining in adipocytes and EC. Adipose tissues fromVE-
cadherin-CreERT2-/-/R26R-/+control mice (A, D, G). 
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A vascular origin for white and brown adipocytes may seem to be in 
contradiction with the work of Seale et al., in which a common origin of BAT and 
skeletal muscle cells [118] was proposed. In this work, the authors found expression 
of YFP in skeletal muscle and BAT from Myf5-Cre/R26R3-YFP mice, consistent 
with both these tissues being derived from a myogenic, Myf5 expressing progenitor. 
Interestingly, De Angelis et al. have shown the existence of progenitor cells from 
embryonic dorsal aorta that express both myogenic and endothelial markers including 
Myf-5 and VE-cadherin[149]. Thus, one explanation for the results of Seale et al. and 
ours is that BAT is derived from a population of VE-cadherin positive, Myf5 positive 
cells, while muscle can be derived from Myf5 only positive cells. Alternatively, as the 
Myf-5-Cre mouse model labels multiple cell lineages from somite origin [150], other 
somite-derived cell progenitors that subsequently express VE-cadherin could in 
theory give rise to BAT. If the brown adipocyte and muscle cell fates were 
determined before the expression of VE-cadherin, lineage tracing experiments using 
the VE-Cadherin-Cre mouse model would not label myocytes.  
 
Human adipose tissue endothelial sprouts give rise to adipocytes 
 The finding that murine cells with endothelial characteristics can give rise to 
adipocytes prompted us to investigate whether human adipocytes share this origin. 
Fragments of human adipose tissue give rise to capillary sprouts when embedded in 
Matrigel, and cultured in pro-angiogenic media [139]. Classical EC ultrastructural 
features, including tight junctions, irregular nuclei and pinocytic vesicles were seen in 
cells comprising these sprouts (Figure 2.5A-D). In regions more proximal to the tissue 
explant, capillary lumens could be observed (Figure 2.5E-G), indicating that 
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angiogenic development is recapitulated ex vivo. Upon exposure to the PPARγ agonist 
rosiglitazone, many cells within the emerging capillary sprouts produced lipid 
droplets (Figure 2.5H-J). These cells displayed canonical ultrastructural features of 
white adipocytes, including a large lipid droplet, displaced nucleus, small and 
elongated mitochondria and glycogen particles distributed in the cytoplasm (Figure 
2.5K). Interestingly, these adipocytes showed tight junctions identical to those found 
in sprouting EC, and between EC and pericytes in vivo (Figure 2.5L, compare with 
Figure 2.S1). These results suggest that the processes of capillary expansion and 
adipocyte formation seen in explants ex vivo reflect those occurring in the intact 
organism.  
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Figure 2.5: Effect of rosiglitazone on angiogenic sprouts originating from human 
adipose tissue. A. Capillary outgrown after 15 days of culture in the absence of 
rosiglitazone, indicating areas distal and proximal to the embedded explants. B. 
Enlargement of area distal to the explants. C. Electron microscopy of area similar to 
that shown in B, where tight junctions can be seen to connect cells. D. Enlargement of 
tight junction found between two EC. E. Enlargement of area proximal to the explant. 
F. Electron microscopy of area similar to that shown in E, revealing lumenized 
capillaries formed by EC joined by tight junctions. G. Enlargement of area shown in F. 
H. Capillary outgrowth after 15 days in the presence of rosiglitazone. I. Enlargement 
of area distal to the explant, revealing lipid droplets in cells interspersed among the 
capillary sprouts. J. Area proximal to the explant containing cells harboring larger 
lipid droplets. K. Electron microscopy of lipid-laden cells revealing features of 
classical white adipocytes, and of EC such as the tight junction in the squared area. L. 
Enlargement of area outlined in K.  
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 We then asked whether these morphologically defined adipocytes express 
genes that confer adipocyte function. Induction of mRNAs for Glut4, adiponectin, and 
leptin, and an >100-fold increase in the expression of perilipin mRNA were observed 
(Figure 2.6A, top row) in parallel with decreased expression of EC markers; tight 
junction protein TJP-1, CD34, and KDR (Figure 2.6A, bottom row). In addition, the 
transcription factor Zfp423, considered a marker of adipocyte lineage pre-
determination[124], was detected and increased significantly in response to 
rosiglitazone (Figure 2.6B). The presence of this pre-determination marker, and the 
strong induction of genes that define adipocyte function, is consistent with the 
possibility that cells with endothelial characteristics can give rise to adipocytes in 
human adipose tissue. 
 
To further examine the relationship between endothelial and adipocyte markers at 
a single cell level, we performed immunofluorescence analysis. In the absence of 
rosiglitazone, most cells contained low or undetectable levels of perilipin (Figure 
2.6C), and high levels of von-Willebrand Factor (vWF) (Figure 2.6D). In the presence 
of rosiglitazone, majority of cells became vWF-negative (Figure 2.6F), but exhibited 
typical morphological feature of adipocytes, a perilipin-coated lipid droplets (Figure 
2.6E). Nevertheless, approximately 5% of cells containing perilipin-coated lipid 
droplets also contained vWF (Figure 2.6G). Similar cells containing lipid droplets 
were also found to express adiponectin (Figure 2.6H and I), another specific feature of 
mature adipocytes. These results are consistent with the hypothesis that adipocytes 
arise from EC, or precursors expressing EC features. In line with these observations, 
recent findings indicate that ECs can be converted into mesenchymal stem cells, 
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which can differentiate into adipocytes, chondrocytes and osteoblasts [151]. 
Furthermore, others have described that adipocytes have the potential to rapidly 
acquire an endothelial phenotype in vitro (Planat-Benard et al., 2004), raising the 
possibility that adipocytes and ECs are plastic enough to undergo inter-conversion to 
maintain a homeostatic equilibrium during adipose tissue expansion and reduction. 
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Figure 2.6: Co-expression of endothelial and adipose cell genes in human and 
mouse systems. A. Relative mRNA levels of canonical adipocyte (top row) or EC 
(bottom row) genes in capillary outgrowth from explants grown for 14 days in the 
absence (-R) or presence (+R) of rosiglitazone. B. Relative mRNA levels of the 
adipocyte pre-determination marker Zfp423. Plotted are the means and SEM of 6-8 
independent experiments. Statistical significance was assessed by non-paired, two 
tailed student t-test *=p<0.05; **=p< 0.001; C, D. In absence of rosiglitazone cells 
growing from human adipose explants are mostly perilipin-negative (green) and vWF-
positive (red). E-G. In the presence of rosiglitazone, perilipin coating around lipid 
droplets is present (E), with majority of cells becoming vWF-negative (F), and about 
5% of cells co-expressing  perilipin (green) and vWF (red) (G).H, I. Cells growing 
from adipose explants, that accumulate lipid droplets in the presence of 
rosiglitazone(I) are also adiponectin-positive (H).  
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Figure 2.6 
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Expression of VE-cadherin in adipocyte progenitors characterized by stem-cell 
markers. 
 To further examine the possibility that adipocytes and EC derived from each 
other or share a common precursor, we asked whether cells expressing adipocyte stem 
cell markers [108], were also positive for VE-cadherin (CD144). CD45- cells from the 
SVF were successively gated for the presence of CD29, CD24 and Sca1 (Figure 
2.7A). Approximately 5% and 10% of the cells in the SVF of eWAT and BAT, 
respectively, were CD45-CD29+CDC24+, and this difference was statistically 
significant (Figure 2.7B, upper panel). Approximately 17% and 52% of the CD45-
CD29+CDC24+Sca-1+ population in eWAT and BAT, respectively, were also 
positive for VE-cadherin (CD144) (Figure 2.7A), comprising 0.5% and 4% of the 
cells in the SVF of eWAT and BAT, respectively (Figure 2.7B, lower panel). The 
percentages of adipogenic stem cells expressing VE-cadherin is in line with the 
amount of endothelial-pericytic cells found in WAT by EM studies in vivo and the  
much larger proportion of VE-cadherin positive cells in BAT is consistent with its 
denser vascular network. These data support the hypothesis of an endothelial origin of 
adipocyte populations in these depots. 
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Figure 2.7. Adipocyte progenitors express VE-Cadherin (CD144) A. FACS analysis 
scheme of cells from SVF of eWAT and BAT. B. Comparison of CD45-CD29+CD24+Sca1+ 
population and CD45-CD29+CD24+Sca1+CD144+ (ASCM+) between depots. C. Gating 
strategy for experiments. **p< 0.005 and *p < 0.00005 and derived from two-tailed student t-
tests, n = 3-4. Fluorescence minus one antibody controls are in Figure 2.S4. 
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 In summary, we present morphological and genetic evidence that adipocytes in 
white and brown depots originate from cells that display endothelial characteristics. 
Further research to identify the physiological signals that determine adipocyte and/or 
EC fates will lead to a better understanding of the mechanisms responsible for 
coordinating the formation of new adipocytes with angiogenic expansion during 
adipose tissue growth.  
 
EXPERIMENTAL PROCEDURES 
Animals 
 Male Sprague Dawley rats and B6 Mice (Harlan, Udine, Italy) were studied at 
different developmental stages. At least 5 animals per group were used for 
morphological studies performed by light, confocal, electron microscopy and 
immunohistochemistry. Homozygous VE-cadherin (VE-cadherin-Cre-recombinase) 
transgenic mice were crossed to homozygous ROSA26R (R26R) reporter and ROSA-
eGFPR lines (Jackson Labs., Bar Harbor, ME; stock n. 6137, 3474 and 4077 
respectively) to reveal the activity of the Cre-recombinase by detection of LacZ and 
eGFP reporter genes. The VE-cadherin-R26R and VE-cadherin-eGFPR mice were 
studied at developmental stage E18 (± 12h) and at P6-8. Heterozygous VE-cadherin 
tamoxifen-inducible Cre-recombinase transgenic mice (VE-cadherin-CreERT2) were 
crossed to homozygous R26R reporter animals. VE-cad-CreERT2/R26R mice (8 
weeks old) were IP injected with tamoxifen (2mg/day) for five consecutive days [134]. 
After injections, mice were fed normal diet with or without rosiglitazone 
(10mg/kg/day) for three weeks. Mice were then sacrificed, and brown and white 
adipose tissue from epididymal and inguinal depots was harvested for X-gal staining. 
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Animal care and handling were in accordance with Italian Institutional Guidelines and 
the Animal Care and Use Committee at UMass Medical School. 
 
Light microscopy and immunohistochemistry 
 Mouse and rat embryos were collected after mother perfusion with 4% 
paraformaldehyde in 0.1M PB pH 7.4 and fixed by overnight immersion in the same 
solution. Each embryo was then dehydrated, paraffin embedded and oriented to be 
cross-sectioned through the interscapular region (head-neck). Newborn rats and mice 
were perfused intracardially using the same fixative; bilateral testis with peri-
epididymal fat were dissected and embedded in paraffin. Light microscopy, 
immunohistochemistry and confocal microscopy were performed using standard 
methods described in the Supplementary Methods. 
 
Electron microscopy and immuno-gold staining 
 After perfusion, small fragment of iBAT of fetal and postnatal eWAT were 
fixed in 2% glutaraldehyde – 2% paraformaldehyde in 0.1M PB pH 7.4 for at least 4 h, 
post-fixed in a solution of 1% osmium-tetroxide and - 1% potassium hexacyanoferrate 
(II), dehydrated in acetone and finally epoxy-resin embedded. Sectioning, mounting 
and examination are further described in the Supplementary Methods. 
 
X-gal staining for β-galactosidase tissue localization 
 Male E18-19 and P6-8 and adult VE-cadherin-Cre/R26R mice were fixed in 
2% paraformaldehyde, 0.25% glutaraldehyde in PBS pH 7.3 for 1 h and washed in 
PBS. Thick (500µm) cross-sections through the interscapular region (head-neck) of 
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iBAT and Ewat were stained for β-galactosidase with the chromogenic substrate X-
gal, sectioned, counterstained and imaged as described in the Supplementary 
Methods.  
 
Human adipose tissue explants 
 Human scWAT was obtained from discarded tissue of patients undergoing 
panniculectomy at UMASS Memorial Hospital. Pieces of 1mm3 were prepared and 
embedded in Growth Factor Reduced Matrigel (BD Biosciences)on 35 mm glass-
bottom culture dishes (MatTek Corporation) as described previously (Gealekman et 
al., 2011), in the absence or presence of 1 µM rosiglitazone maleate. After 14 days in 
culture immunofluorescence was performed as described previously (Gealekman et al., 
2011). Primary antibodies used are stated in the Supplementary Methods. For RT-
qPCR, the adipose tissue fragment was mechanically excised and the endothelial 
sprouts remaining in the Matrigel were isolated using Dispase II (Roche, 2.4 U/mL), 
centrifuged, and RNA extracted from the pellet using an Ambion RNA extraction kit. 
Probes used are specified in the Supplementary Methods.  
 
Fluorescence Activated Cell Sorting 
SVF from eWAT or inter-scapular brown fat pads from 8 week old mice were isolated 
as described [152], and stained with blue stain (Invitrogen) at 4°C for 20 min. Cells 
were incubated with anti-mouse CD16/CD32 (BD Biosciences) for 15 min and then 
with respective FACS antibody for 2h at room temperature. Antibodies used are 
stated in the Supplementary Methods. 
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Figure 1.S1: Morphological analysis of eWAT at P7. A-D. Nuclear staining of poorly 
differentiated cells in pericytic position (arrows), and adipocytes (L; lipid droplet), for 
transcription factors indicated in each panel. In D the nucleus of EC (indicated by 
arrowhead) also positive for C/EBPβ. E.EC joined to adjacent pericyte with a tight 
junction between a protrusion of its cytoplasm that crosses the basal membrane and the 
complementary indentation in the pericyte. The inset is an enlargement of the squared 
area. F. Hypothesis based on data shown in Figure 2 that describe developmental stages 
from endothelium to preadipocytes. 
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Figure 1.S1 
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Figure 2.S2: VE-Cadherin lineage tracing in WAT and BAT. Histological 
appearance of eWAT obtained from VE-cadherin-Cre/R23R (A) or VE-cadherin-
Cre(B)adult mice subjected to X-gal staining. C. X-gal crystals in the cytoplasm of 
EC (e), pericytes (p) and adipocytes (a) found in eWAT of 4 weeks old VE-cadherin-
Cre/R26R mice (arrows). D. Positive X-gal staining of eWAT preadipocyte (multiple 
small lipid droplets in the cytoplasm). E. eGFP localized in the vessels (V in inset), 
and adipocytes (asterisk)of VE-cadherin-Cre/eGFPR mice. n: nucleus.  
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Figure 2.S2 
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Figure 2.S3: Structural characteristic and lineage tracing support common 
origin of developing endothelial and fat cells. A. PPARγ positive staining (dark 
brown) of murine E18 brown adipocytes in interscapular BAT.B. UCP-1 
immunohistochemistry of a serial section showed in A, revealing BAT staining and 
surrounding muscle being negative. C-E. Higher magnification images highlighting 
the positive staining for transcription factors involved in BAT development (PPARγ; 
C/EBPβ; C/EBPα) all in brown adipocyte nuclei. F-G. UCP-1-immunogold staining 
(black dots) showing positive mitochondria in brown adipocytes (ba, magnification in 
the inset), as well as in poorly differentiated cells (p) in pericytic position (G is an 
enlargement of the squared area in F). H. Some endothelial cells (e) showing 
mitochondria similar to those of poorly differentiated preadipocytes, close to the 
capillary wall. I. Enlargement of the red squared area in H outlining this 
similarity(asterisk indicating the lumen of capillaries).J-L. scWAT showing the 
appearance of X-gal labeled multilocular adipocytes (arrows) in rosiglitazone-treated 
VE-cadherin-CreERT2-/+/R26R-/+ mice. 
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Figure 2.S3 
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Supplementary Figure 4: FACS gating strategy. Respective fluorescence-minus-
one plots used to define gates in FACS experiments, relating to Figure 4. 
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CHAPTER III: The microenvironment and adipogenesis 
 
 
 
Olga Gealekman performed the microscopy work described in this chapter. Khanh-
Van Tran performed the real-time PCR experiments. The study of regional differences 
between thoracic and abdominal aorta was a collaboration between the Corvera and 
Czech laboratories. Experiments were in parts designed by Timothy Fibzgibbons, 
Olga Gealekman and Khanh-Van Tran. 
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Summary: 
Previously, we have demonstrated that cells from an endothelial lineage of 
adipose tissue can give rise to adipocytes. Here we investigate whether endothelial 
cells originating from aortic rings of C57Bl/6J mice have the capacity to undergo 
adipogenesis. We find that in the presence of the PPARγ agonist, rosiglitazone, cells 
with endothelial characteristics accumulate lipid droplets, express canonical adipocyte 
markers, and secrete adipokines. Furthermore, we investigated whether cells from 
thoracic and abdominal regions of the aorta have genotypic and phenotypic 
differences. We found that progenitors from different regions of the aorta express 
different levels of developmental gene Hoxc9. Cells from these distinct areas have 
different proliferative dynamics and give rise to distinct adipocyte types.  Taken 
together, these results imply that progenitor cells from a non-adipose organ may have 
capacity to undergo adipogenesis and that microenvironment is crucial in determining 
genotype and phenotype of cells.  
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Introduction: 
 We recently found that progenitors of an endothelial cell lineage residing in 
the adipose tissue vasculature have the ability to give rise to a population of 
adipocytes [153]. There are reports of multiple stem cell niches in different organ 
systems [154-157]. In this chapter, we address the hypothesis that endothelial cells 
from aortas of mice are able to give rise to new adipocytes. 
In 1990, Nicosia and Ottinetti designed aortic ring assay to study angiogenesis 
[158].  This development provides a semi-isolated model of angiogenesis while 
preserving some of the microenvironment that is representative of the physiological 
process. Cells arising from aortic rings form tubular structures and lumenize. 
Furthermore, the time course of this process mimics in vivo process [159]. Since its 
first introduction, this method has been widely used to study the development of new 
vessels, as it bridges the gap between in vivo animal work and in vitro cell culture 
[159-162].  
In this study, we used the aortic ring assay to study progenitor cell plasticity. 
When cultured in EGM-2, vast majority of cells (over 90%) arising from the aortic 
ring express endothelial cell markers. There is also a small subset of cells (around 
5%) that express pericyte marker, SMA. In this study, we used PPARγ agonist to 
stimulate adipogenesis in cells emerging from aortic explant. In the presence of 
rosiglitazone, we observed that cells expressing endothelial markers begin to take on 
adipocyte morphology. To confirm that these cells are adipocytes, we checked for 
expression of adipocyte genes at the transcriptional and translational levels. We found 
that rosiglitazone decreases the expression of endothelial cell makers and increases 
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the expression of adipocyte markers. Furthermore, rosiglitazone-induced adipocytes 
secrete adiponectin, a hallmark adipokine. Taken together, we show that cells arising 
from the aorta of C57/Bl6 mice can give rise to functional adipocytes. 
There have been several reports that adipocytes have different characteristics 
depending where they are located in the body [83, 163-­‐165]. Tchoukalova et al. 
recently demonstrated that subcutaneous femoral fat and abdominal fat have different 
proliferative dynamics. Fat accumulating in the femoral area tends to undergo 
hyperplasia, whereas fat in the upper abdominal area tends to undergo hypertrophy in 
the presence of overfeeding [84]. They attributed this observation to differences in the 
progenitor cell population.  
In this study, we aim to study preadipocyte populations between the thoracic 
and abdominal regions of the aorta. We attempt to measure the proliferative capacity 
of the precursor cells by quantifying the endothelial sprouts arising from the aortic 
rings. We also examined the expression levels of classical adipocyte genes in the 
rosiglitazone-stimulated fat cells from different regions of the aorta. Results reported 
here are very preliminary. However, our experiments show that progenitor cells from 
the thoracic and abdominal aorta express different levels of the developmental gene, 
Hoxc9. Furthermore, the adipocytes they give rise to may be distinct.  
 
Experimental Procedures: 
 
Aortic Ring Assay: C57Bl/6J mice were sacrificed and thoracic and abdominal aorta 
fragments were removed. The two fragments of aorta were then cleaned under 
dissection microscope to ensure that all associated fat and connective tissue were 
removed. The aortic fragments were washed with EGM-2 media and cut into 1 mm 
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ring segments. Each aortic ring segment was embedded in a singular well of a 96-well 
plate containing 40 µL of Matrigel (BD Discovery Labware). After aorta was 
embedded in the 96-well plate, the plate was allowed to stand for 30 min in the 37° C 
so that the Matrigel would solidify. The cells were fed with 200 µL of EGM-2 media, 
which was changed every other day. At day 7 and day 14, number of capillary 
branches forming around the periphery of the aortic ring was quantified at x100 
magnification by two independent investigators.  
 
Staining and Analysis: Pieces of aortic rings were embedded in Growth Factor 
Reduced Matrigel (BD Biosciences) in 35 mm glass-bottom culture dishes (MatTek 
Corporation), and cultured in EGM-2 media for 14 days. After 14 days in culture, 
explants were fixed in 4% Formaldehyde (Ted Pella, Inc.) in PBS for 15 min and 
permeabilized in 0.5% TX-100 in PBS for 30 min. The primary antibodies used to 
characterize the origin of cells growing from the explants were: monoclonal mouse 
eNOS (BD Pharmingen, 1:200), mouse CD31 (1:50), mouse CD34 (1:50), mouse 
monoclonal Smooth Muscle Actin (1:100), polyclonal rabbit Von Willebrand Factor 
(Dako, 1:100), monoclonal mouse Adiponectin (Peirce, 1:200), and polyclonal 
Guinea Pig Perilipin (Fitzgerald Industries International, 1:200). Secondary antibodies 
were species matched Alexa Fluor 594, and Alexa Fluor 488 (Millipore; Molecular 
probes, 1:500). Negative controls treated with irrelevant mouse IgG instead of 
primary antibody were processed simultaneously. All sections were counterstained 
with DAPI (Millipore, Molecular Probes).  
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Real-Time PCR: The mouse aorta fragments were mechanically excised and the 
endothelial sprouts remaining in the Matrigel were isolated using Dispase II (Roche, 
2.4 U/mL), centrifuged, and RNA extracted from the pellet using an Ambion RNA 
extraction kit. Probes used are specified in Table 2. 
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Western Blotting: The mouse aorta fragments were mechanically excised and the 
sprouts remaining in the Matrigel were isolated using Dispase II (Roche, 2.4 U/mL). 
Cell lysates were prepared using the Complete Lysis-M kit (Roche). Protein 
concentration was measured using the Beckman DU-640B Spectrophotometer. Equal 
amounts of protein (20 µg), and conditioned media (40 µl) were loaded, and analyzed 
by Western blot in accordance with standard procedure. Primary antibody used was 
rabbit polyclonal anti-Adiponectin (Peirce, 1:10000). Secondary was goat anti-rabbit 
(Promega). 
 
RESULTS: 
We found that in the presence of rosiglitazone, cells arising from the aorta can 
accumulate lipid droplets (Figure 3.1). The morphology of cells is no longer spindle-
like, rather they resemble multilocular fat cells. Oil-Red-O staining clearly identified 
lipid droplets in cells coming from the aorta (Figure 3.2) 
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To confirm that these cells are adipocytes and not endothelial cells 
accumulating lipid droplets, we used immunoflourescence and real-time PCR to 
check for the expression of several adipocytes and endothelial markers. We found that 
in the presence of rosiglitazone, the expression of CD31 is decreased and the 
expression pattern of CD34 is distinctly altered (Figure 3.3). Conversely, the 
expressions of adiponectin and perilipin are increased. In particular, perilipin 
expression pattern in these cells is consistent with that of an adipocyte, i.e. 
surrounding a lipid droplet. The reciprocal change in endothelial cell and adipocyte 
markers observed using immunoflourescence is consistent with real-time PCR results 
demonstrating a decrease in endothelial cell markers, VE-Cadherin, CD34 and 
VEGFR2 and an increase in adipocyte markers, Acrp30, Glut4 ,and Cidea (Figure 
3.3). We further tested cell lysates and condition media of sprouts growing from aorta 
explants for the expression and secretion of adiponectin. We confirmed that these 
rosiglitazone-induced fat cells are secreting adiponectin, a hallmark adipokine (Figure 
3.4). 
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Figure 3.3. Reciprocal changes in endothelial cell and adipocyte markers. In the 
absence of rosiglitazone, cells arising from aortic rings are positive for CD31 (A) and 
CD34 (B), but are negative for adiponectin (C) and perilipin (D). In the presence of 
rosiglitazone, expression of CD31, and CD 34 (E and F) is altered, and there is an 
increase in the expression of adiponectin and perilipin (G and H). Furthermore, 
mRNA levels of cells arising from aortic rings at day 14 in culture in the absence (I) 
and presence of rosiglitazone (J) were assessed. There is a statistically significant 
increase in adipocyte markers, Acrp30, Glut4, and Cidea, and a reciprocal decrease in 
endothelial cell markers VE-Cadherin, CD34, and VEGFR2. n=3-6, data were 
analyzed using student t-test, *p < 0.05. 
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Figure 3.3 
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Figure 3.4. Rosiglitazone-induced adipocytes express and secrete adiponectin. 
Immunofluorescent analysis of Adiponectin expression in capillary sprouts forming 
from aorta explants under control conditions (A, and B), and in the presence of 
Rosiglitazone (C - F). Positive Adiponectin specific immunostaining was observed 
only in Rosiglitazone treated cells. A, C, and E are bright light microscopy images. B, 
D, and F are merged from the images taken using UV and green spectrum filters. 
Original magnification was x630.  G. Western blot analysis of adipocyte marker 
Adiponectin in capillary sprouts growing from aorta explants under control conditions 
(-R) and in the presence of Rosiglitazone (+R). Rosiglitazone induced expression of 
Adiponectin in the cell lysates, as well, as secretion of Adiponectin into the media. 
Normal mice serum (S) was used as a positive control for Adiponectin detection. 
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We then asked if adipocyte precursors in different regions of the aorta are 
unique (Figure 3.5). Interestingly, we found that abdominal aorta has higher mRNA 
levels of Hoxc9, a homeobox gene expressed higher in WAT than BAT [163, 166]. 
Although, we found no differences between expression of Sca-1, and CD24 in these 
populations, it is clear that rosiglitazone decreases the expression of CD24 (Figure 
3.6). 
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Figure 3.5. Capillary sprouts arise from both abdominal and thoracic aorta 
fragments. Cells arising from thoracic (B) and abdominal (E) rings were analyzed in 
the absence (C and F), and in the presence of rosiglitazone (D and G). Rosiglitazone 
induced the formation of multilocular adipocytes from both segments of aorta. 
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Figure 3.6. mRNA levels of developmental and precursor genes. Thoracic and 
abdominal regions of the aorta had different levels of expression of Hoxc9 (A). 
Although no difference in Sca-1 or CD 24 expression (B and C), we found that the 
expression of CD24 was decreased in the presence of rosiglitazone (C). 
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We also examined the growth of capillary sprouts from the thoracic and 
abdominal regions of aorta. We found that significantly lower number of capillary 
sprouts grew from the abdominal aortic rings of the mice, as compared to the thoracic 
(Figure 3.7). We further tested to see if the adipocytes stimulated to form by 
rosiglitazone in different areas of the aorta were genotypically different. We found 
that rosiglitazone increased the expression of adiponectin, Glut4, and perilipin in cells 
arising from the abdominal and thoracic aortic rings. This same trend was observed 
with Cidea and UCP-1, canonical brown adipocyte genes. However, we observed that 
adipocytes arising from the thoracic aorta had much higher expression of both Cidea 
and UCP-1 (Figure 3.8). 
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Figure 3.7. Abdominal aortic explants have less angiogenic potential. Quantitative 
analysis of angiogenic potential of abdominal and thoracic aorta explants from mice 
cultured for 14 days. Abdominal and thoracic aortas were surgically removed from 13 
weeks old C57Bl/6J mice, embedded into Matrigel, and cultured for two weeks. After 
7 and 14 days in culture number of capillary sprouts growing around perimeter of the 
aorta rings was counted by two independent investigators. Data was analyzed using 
student t-test, *p<0.05 and **p<0.001  
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Figure 3.8. Differential gene expression in rosiglitazone-induced adipocytes from 
abdominal and thoracic aortic explants. Rosiglitazone increased the expression of 
perilipin, adiponectin, Glut4, UCP-1, and Cidea in cells arising from the aorta (A and 
B). However, the up-regulation of UCP-1 and Cidea in cells from the thoracic aortic 
region was much higher than that observed in cells from the abdominal aortic region. 
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Discussion: 
Using a traditional model of angiogenesis, we found that endothelial cell 
progenitors residing in aorta can also undergo adipogenesis. This study demonstrates 
the plasticity of the progenitor population. These results are consistent with those of 
Joe et al.  who have found that stem cells from muscle can give rise adipocytes [167]. 
It is worth noting that Tang et al. found that PDGFRβ+ cells from the kidneys are not 
able to undergo adipogenesis [91]. They concluded that only mural cells from the 
adipose tissue have adipogenic capacity. Perhaps the reason for the potential 
discrepancies between our results and that of the Graff lab is the difference in the 
microenvironment in which our cells were cultured. In our aortic ring assay, the cells 
have an ex vivo surrounding, in which some of the paracrine signaling existing 
between cells of the aorta are still preserved.  
 One obvious limitation stemming from the ex vivo model is that we are not 
completely sure about the identity of the cells that give rise to newly-formed 
adipocytes. Our conclusion that cells of endothelial origin from the aorta can give rise 
to adipocytes rests on the assumption that the spindly-like cells that express 
endothelial markers in the absence of rosiglitazone are the same cells that accumulate 
lipid droplets and express adipocyte markers in its presence. It is possible that in the 
presence of rosiglitazone we activated a population of precursors distinct from the one 
that gives rise to endothelial cell. Furthermore, there is a physiological fat pad around 
the aorta. Although we have tried to remove all fat around the aorta using micro-
dissection, there is some possibility that some were left behind. Thus, what we are 
seeing might be adipocyte precursors from a non-endothelial cell lineage undergoing 
adipogenesis.  
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Although there are two clear limitations in our study, our results of the VE-
cadherin fate tracing experiment support the hypothesis that endothelial cells can give 
rise to adipocytes. In the future, we hope to use aortas from the VE-Cadherin/R26R-
eGPF mice to address this limitation.  
 Preliminary evidences from our study of thoracic and abdominal aorta show 
that precursor cells from different regions of the aorta have different genotypes and 
proliferative dynamics. Cells from the abdominal region of the aorta express higher 
levels of Hoxc9, a developmental gene that is expressed higher in WAT than BAT 
[163, 166]. In the presence of rosiglitazone, the progenitors also give rise to 
adipocytes that are unique. Adipocytes arising from the thoracic aorta have higher 
expression of UCP-1 and Cidea. This data indicate that the cells surrounding the 
thoracic aorta may have more of a “brite cell” phenotype, as opposed to a white 
adipocyte phenotype seen in fat cells surrounding the abdominal aorta [166]. Police et 
al. have reported that there are differences in aortic fat pads that may have a causative 
role in abdominal aortic aneurysm [168]. Our preliminary results support the notion 
that the adipocytes in different regions of the aorta have distinct characteristics. It was 
not our intention to study the pathogenesis of abdominal aortic aneurysm, however we 
do think that this ex vivo aortic ring model can give valuable insight to the role that 
adipocytes play in different regions of the aorta.  
Our preliminary results also show that rosiglitazone decreases the expression 
of CD24 in the cells arising from the aorta. This is consistent with the findings of 
Tang et al. that chronic rosiglitazone treatment lowers CD29, Sca-1, CD44 and CD24 
expression in progenitors cells by either depleting the precursor population or 
changing precursor dynamics [148].  
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In brief, our preliminary evidence suggests that precursor cells from an 
endothelial lineage arising from the aorta can give rise to adipocytes. The genotypes 
and proliferative dynamics of the progenitor cells from different regions of the aorta 
are distinct. Furthermore, the adipocytes that they give rise to are also unique and may 
have important physiological function.  
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CHAPTER IV: Summary and Final Thoughts 
 
 
“For animals, belonging to two most distinct lines of descent, may have become 
adapted to similar conditions, and thus have assumed a close external resemblance; 
but such resemblances will not reveal—will rather tend to conceal their blood-
relationship.” 
 
Darwin, On the Origin of Species, 1st ed., p. 427 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 89 
 
89 
Summary, limitations and future experiments:  
Chapter II: In obesity, adipose tissue growth necessitates the development of new 
adipocytes and associated supporting vasculature. Here we find that endothelial cells 
of adipose tissue display similar morphological features to pericytes, which has been 
shown to give rise to adipocytes. Fate tracing using VE-Cadherin-Cre-dependent 
reporters revealed expression of LacZ and eGFP in endothelial cells, preadipocytes 
and adipocytes of BAT and WAT.  
To examine whether our findings in mice adipose tissue translate to human 
adipose tissue, we analyzed capillary sprouts arising from human adipose explants. 
We found that capillary sprouts arising from human subcutaneous fat express Zfp423, 
a preadipocyte determination factor. In response to PPARγ activation, endothelial 
characteristics of sprouting cells are progressively lost, and cells form structurally and 
biochemically defined adipocytes. Taken together, these data reveal an endothelial 
origin of murine and human adipocytes. The ability of the vascular endothelium to 
give rise to adipocytes may explain how angiogenesis and adipogenesis can be 
temporally and spatially coordinated.  
 Our results are supported by a recent study from the Spiegelman laboratory 
which demonstrated that a subset of pericytes and endothelial cells express Zfp423, a 
marker of adipocyte pre-determination [89]. Moreover, PPARγ deletion using Tie-2-
driven Cre-recombinase results in decreased adiposity and adipocyte size in response 
to HFD-feeding and rosiglitazone treatment [144]. It is important to note that Tie-2 is 
expressed in a mosaic pattern in capillary endothelium [143]. Preferential expression 
of Tie-2 in the arteriolar endothelium may explain how some adipocytes in the 
adipose capillaries may escape PPARγ deletion to give rise to normal adipocytes. 
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However, the presence of normal adipocytes in the knockout animals may also be due 
to the presence of precursors from a non-endothelial cell lineage.  
There are reports of several distinct types of adipocytes—white, brown and 
brite. Within these categories, there are different subsets of cells that have variable 
physiological significance. Our results show that both white and brown adipocytes 
can originate from cells of endothelial origin. However, it is also clear from our FACS 
analysis that not all precursor cells express VE-Cadherin. Of the CD45-
CD29+Sca1+CD24+ progenitor population, only 17% and 52% express VE-Cadherin 
in WAT and BAT, respectively. This analysis illustrates two important points: 1) 
there are adipocyte precursors that do not originate from a VE-Cadherin+ lineage and 
2) the WAT and BAT have variable adipocyte precursor populations. Differences in 
composition and types of adipocyte progenitors may explain the difference in the 
adipocytes phenotypes that we observe in BAT and WAT. 
 Of note, we adopted a similar but altered FACS sorting scheme than that of 
the Graff laboratory to isolate adipocyte progenitors.  We were not able to analyze the 
CD34 expressing cells due to technical challenges. We also felt that because CD34 
can be expressed on both endothelial cell and adipocyte precursors, it was not 
essential for addressing the question asked in this work.  
For the purpose of our study, it was important to rule out that our observations 
are not due to adipocytes arising from a hematopoietic cell lineage, and thus was our 
rationale for negatively selecting CD45 expressing cells. However, we did not analyze 
expression of CD31 or Ter119 in the SVF population. Consequently, we are unable to 
determine what percentage of the SVF population we analyzed is made up of Ter119 
and CD31 expressing cells, which have low adipogenic potential. Interestingly, Gupta 
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et al. have found that CD31 positive cells of the adipose vasculature also express 
Zfp423, raising questions about the adipogenic potential of CD31+ endothelial cells.  
Although this study supports an endothelial origin of a population of 
adipocytes, it does not exclude a hematopoietic origin of adipocytes. VE-Cadherin is 
expressed in endothelial cells and a sub-populations of hematopoietic cells before 
E11.5, and thus descendants from both lines are potentially labelled in our study [136]. 
To decrease the tracing of hematopoietic cells, an inducible VE-Cadherin-CreERT2 
mouse model was used. Induction of Cre activity by Tamoxifen in adulthood results 
in negligible excision (lower than 0.4%) in the hematopoietic lineage [134]. However, 
this does not completely eliminate hematopoietic tracing. Furthermore, even if it was 
possible to trace only endothelial cells, our results cannot exclude the possibility that 
adipocytes can arise from a different lineage. 
A limitation of this study is that it does not conclusively identify the point at 
which either a precursor cell or an endothelial cell is programmed to differentiate into 
an adipocyte (Figure 4.1).  For example, do endothelial cells and adipocyte arise from 
a common progenitor cell that expresses VE-Cadherin? Alternative, are newly formed 
adipocytes created from endothelial cells that have divided and migrated into the 
tissue? Although, endothelial cell division and migration into extravascular space to 
be reprogrammed into a new adipocyte is plausible scenario in the case of obesity. 
The reverse situation in which an adipocyte is stimulated to become an endothelial 
cell seems unlikely. Our FACS analysis revealed that cells expressing CD29, CD34, 
Sca-1 and CD24 also express VE-Cadherin, suggesting that there is an existence of an 
early adipocyte progenitor from an endothelial lineage. However, the mechanism of 
new adipocyte formation is not yet clear. 
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Figure 4.1. Possible sequences of new adipocyte formation. A VE-Cadherin+ 
precursor may give rise to both endothelial cells and adipocytes (A), or adipocytes can 
arise from an endothelial cell that is re-programmed to become a fat cell (B).  
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A natural progression of this project would be to isolate and characterize VE-
Cadherin+ adipocyte progenitors.  These cells can be sorted by FACS using several 
potential models (Figure 4.2). If indeed endothelial cells and adipocytes share a 
common progenitor, then we should observe VE-Cadherin+ cells undergo robust 
adipogenesis. Furthermore, we can use FACS to isolate distinct VE-Cadherin+ 
populations, e.g. populations also expressing Tie-2, to determine molecular signature 
of the adipocyte precursor arising from the VE-Cadherin+ lineage. It would also be 
beneficial to measure insulin sensitivity, mitochondrial content, oxygen consumption, 
and other metabolic parameters of these VE-Cadherin-derived adipocytes, as 
compared to other adipocyte populations. Finally, we should engraft VE-Cadherin+ 
adipogenic precursor cells into lipodystrophic or diet-induced obese animals to assess 
their physiological importance. 
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Figure 4.2. Reporter models for isolation of cells from an endothelial cells lineage. 
Either VE-Cadherin reporter models (A and B) or the Tie-2-GFP mouse model can be 
used to FACS sort endothelial cells and adipocyte progenitors 
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Chapter III: We find that rosiglitazone can stimulate cells with endothelial 
characteristics originating from the aorta to undergo adipogenesis, resembling the 
phenomenon we observed in human adipose tissue explants. Rosiglitazone-induced 
adipocytes from the thoracic and the abdominal regions of the aorta display different 
characteristics; cells from the thoracic aorta express higher levels of UCP-1 and Cidea, 
traditional brown adipocyte genes. The genotypic differences observed in adipocytes 
surrounding the aorta may have important physiological implications. For example, 
inflammation of adipose tissue surrounding the abdominal aortic region may be 
involved in the pathogenesis of abdominal aortic aneurysms [168]. The aortic ring 
assay may be a valuable tool to study the role that adipocytes play in pathologies 
relating to the abdominal or thoracic aorta. 
Despite the fact that the aortic ring assay is a classical assay extensively used 
by numerous investigators to study angiogenesis ex-vivo, to the best of our 
knowledge, lineage tracing experiments to prove the endothelial origin of cells 
forming the capillary sprouts were never performed. Therefore, in order to obtain 
stronger evidence that cells of endothelial origin capable to undergo adipogenesis are 
present in other organs, aortic ring assays using VE-Cadherin-CreERT2/YFP or eGFP 
reporter mice should be performed (Figure 4.2). 
In addition, although results obtained using the ex vivo model are valuable, 
they represent an artificial process.  Cells arising from the aorta or any other organ 
systems in vivo will never be subjected to the experimental conditions that we 
imposed; thus our results may not be reflective of normal physiology. However, these 
models allow us to study the differentiation potential of cells outside of the in-vivo 
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environment and to interrogate the paracrine signaling involved that would be 
challenging to study in a live animals. 
 
On multiple origins of adipocytes: Although our study clearly shows that a population 
of adipocytes is derived from an endothelial cell lineage, it does not exclude alternate 
origins of adipocyte. As many others have shown and as supported by our FACS 
analysis, adipocytes can come from other cell lineages. Although it has been 
mentioned in Chapter II, we will briefly discuss the results of Seale et al. The 
Spiegelman laboratory showed that muscle cells and brown adipocytes are Myf5+, 
and that PRDM16 controls the switch between myocytes and fat cells phenotype 
[118]. They report that white adipocytes are not Myf5+. Thus, it is somewhat 
surprising that in our study VE-Cadherin reporters traced into white and brown 
adipocytes, but not into myocytes. One possible explanation for this is that VE-
Cadherin is expressed later in development than Myf5. In that case the brown 
adipocyte lineage and the myocyte lineage have already diverged, and thus our model 
would not have labeled myocytes. There is little evidence in the literature to 
determine the expression pattern of these two genes in relation to each other.  
It is also important to note that Myf5+ is not strictly a myocyte marker, but is 
expressed in several cell types [169]. Expression of Myf5+ has been found in neurons 
and in a population of cells from the dorsal aorta that also expresses VE-Cadherin 
[149, 170, 171]. Reports also indicate that not all muscle cells expressed Myf5 [172]. 
In this study, we detected a low level of Myf5 mRMA expression in capillary sprouts 
originating from human subcutaneous fat and mouse aorta.  However, because 
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presence of other cells types in addition to endothelial cannot be completely excluded, 
question regarding Myf5 expression in endothelial lineage cells remains open.  
Additional explanation that would bridge our study and that of the 
Spiegelman’s group would be that brown adipocytes arise from multiple cell lineages, 
some of which are Myf5+, and some are Myf5-. Seale et al. supports this hypothesis 
by demonstrating that β-adrenergic-stimulated mutilocular adipocytes are not Myf5+.  
Reports of white fat cells taking on brown fat cell phenotype upon cold exposure 
illustrates brown fat formation from a Myf5- cell, indicating that there could be 
multiple origins of brown adipocytes.  
Others have shown that cells of a hematopoietic lineage can give rise to 
adipocytes [118, 145, 173]. Most significantly, the Majka et al. have performed fate 
tracing experiments using the LysM-Cre/R26R mouse to show a population of 
adipocytes originating from a myeloid lineage. To further support this, Sera et al. 
have shown that eGFP+ hematopoietic stem cells (HSC) give rise to adipocytes when 
engrafted into recipient mice.  It is also important to note that Zovein et al. have 
demonstrated that endothelial cells and hematopoietic cells arise from the same origin 
[135]. Thus, evidence supporting the origins of adipocytes from HSC and endothelial 
cells may not be mutually exclusive.  
Recently, Billon et al. described a population of adipocytes originating from 
the neuroectoderm.  Sox10 is highly expressed in migratory neural crest cells; 
however it is not expressed in somatic and cephalic mesoderm. Billon et al. used 
Sox10-Cre/YFP reporter mice to show that adipocytes from the jaw are derived from 
cells of the neural crest [174, 175]. Because of the great heterogeneity within and 
between fat depots [84, 123], it makes biological sense that there are multiple 
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phenotypically and genotypically different progenitors. Figure 4.3 maps conclusions 
from some of the most recent studies on adipocyte precursor cells. 
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Figure 4.3.  Model for multiple origins of adipocytes.  Neural crest cells (Sox10+) 
can give rise to white adipocytes (A). Most adipocytes are considered to be of 
mesodermal origin (B). It is reported that hematopoietic cells and endothelial cell 
have common precursor, the hemangioblast. After diverging into the hematopoietic 
lineage and endothelial lineages, cells from both lineages were found to have the 
capacity to undergo adipogenesis. Progenitor cells that are My5+ can give rise to a 
population of muscle cell and brown adipocytes, but not white adipocytes. Questions 
remain about the sequence of events by which new adipocytes are formed, and 
whether there is enough plasticity for inter-conversion in between phenotypes. 
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 The current body of evidence on adipocyte progenitors suggests multiple 
origins of adipocytes. This may reflect the vital role of storing energy in the body. All 
organ systems, regardless of their function, must store nutrients to survive. The most 
efficient way to store energy is through fat. There are reports of fat storage in multiple 
cell types in the animal kingdom. For example, C. elegans stores fat in the intestinal 
epithelium and sharks store fat in the liver [40]. Perhaps it is not too surprising that 
we find multiple cell types able to take on the adipocyte phenotype in mammals. 
 The concept that several cells types can be reprogrammed to take on a 
different phenotype for the benefit of an organ has been previously demonstrated. For 
example, Morroni et al. has shown that there is reversible trandifferentiation of 
adipocyte and secretory epithelial cells of the mammary gland [176]. During 
pregnancy, adipocytes of the mammary glands can transdifferentiate into secretory 
epithelial cells. Post-lactation, these cells revert back to their initial adipocyte 
phenotype. A less drastic example of transdifferentiation is between brown and white 
adipocytes. In case of cold exposure, white adipocytes of the adipose tissue will take 
on a “brown” phenotype and express UCP-1 [119]. Pathological reprogramming is 
illustrated by the heterotrophic ossification in patients with fibrodysplasia osssificans 
progressiva. Cells that make up ectopic tissue are found to be of vascular endothelial 
origin carrying a mutation in the activin-like kinase-2 gene [151]. Although, the 
mechanisms of cellular reprogramming are mostly undiscovered, it is clear that 
physiological and pathological conditions influence cell fate. 
In obesity, the environment drives each organ to store fat. Although, the 
phenomenon of adipocytes forming in different organs from multiple cell lineages is 
not an example of convergent evolution, it may operate on the same principle within a 
 101 
 
101 
shorter time frame and on a microcosm. In order to adapt to an excess of nutrients, 
each system makes its own fat cells. This work does not conclude that every organ has 
a distinct fat cell progenitor, but rather postulates that in order to adapt to the overfed 
state, the body makes new fat cells, and that the cell lineage of the precursor is likely 
to be secondary to the immediate needs of the organ. 
 
Future directions and significance: In moving forward, we should characterize the 
VE-Cadherin+-derived adipocytes, and determine the molecular signals that drive 
them towards differentiation. Although, the developmental aspects of this study are 
engaging, the prospect of identifying the progenitor stem cells and using those stem 
cells to treat patients who are lipodystrophic or have other obesity-related 
complications is most exciting. As Rodeheffer et al. have shown, injection of a small 
population of progenitor cells can reconstitute fat pad of a lipodystrophic animal and 
correct their metabolic impairment. Identifying the population of stem cells that gives 
rise to healthy white adipocytes can have profound implication for patients suffering 
from congenital or drug-acquired lipodystrophies. 
 Brown adipose tissue has been correlated with lower BMIs and greater 
metabolic health. Generating brown fat in people may be an effective anti-obesity 
treatment. Here, we find a common precursor to both brown and white adipocytes. 
Elucidating the pathway in which white to brown conversion occurs may provide a 
strategy for combating the obesity epidemic affecting our society.  
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Appendix I: Preliminary study of adipose tissue of NSG and huNSG mice 
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Introduction: 
 Hematopoietic origin of adipocytes has been proposed by several different 
groups [145, 173, 177]. We decided to examine this hypothesis using a mouse model 
that has severe disruption of hematopoietic cell development. The Schultz and Greiner 
laboratories have developed a NOD-Scid-Gamma (NSG) animal model by generating 
an additional mutation in the interleukin-2 receptor γ-chain locus of a NOD-scid 
mouse [178]. These NSG animals do not have mature T-cells, B-cells, and natural 
killer cells. A great advantage of this model is that the NSG mice can support 
hematopoietic stem cell engraftment derived from human cord blood (huNSG). This 
allows for the presence of human HSC, and immune cells that theoretically could be 
traced with human anti-nuclear antibodies [179-182]. In this work, we asked whether 
the NSG mice and the huNSG could gain weight on high fat diet (HFD). We show 
very preliminary data that the fat pads of NSG mice increase in weight on HFD. No 
conclusions were reached regarding the huNSG mice due to technical challenges.  
 
Results and discussion: 
After one month of HFD feeding, we found that fat pads of NSG HFD-fed animals 
were increased in weight compared to the normal diet (ND) fed animals (Figure A1.1). 
This increase is a trend and not statistically significant. The same trend was not 
observed in the huNSG groups partially because some animals did not survive long 
enough for HFD effect to be analyzed. Unfortunately, we were unable to find the right 
conditions for the human anti-nuclear antibody to detect human cells. No significant 
trend was noticed in the weight of the animals (Figure A1.2). This may also be due to 
their ill health and the short time period for which they were on HFD. These results 
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are very preliminary and very little conclusions can be made. However, we would like 
to note that mice with severe impairment in hematopoietic cell lines have 
morphologically normal adipocytes and that their fat pads seems to increase in weight 
on HFD (A1.3). 
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Figure A1.2. NSG and huNSG mice on HFD. No trend was observed in weights of 
NSG and huNSG mice on normal chow diet (A and C) and high fat diet (B and D). 
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Experimental Procedures: 
NSG and huNSG mice were kindly donated by the Greiner laboratory. At 15 weeks, 
they were placed on HFD for 31 days, during which time their body weight were 
monitored. After a month on HFD, the mice were sacrificed and their fat pads were 
measured. 
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